TSE:PRN Profound Medical (PRN) Price, Holdings, & News C$11.10 -0.11 (-0.98%) As of 03:59 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartFDA EventsHeadlinesHoldingsRatingsBuy This Stock About Profound Medical (TSE:PRN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Profound Medical alerts:Sign Up Key Stats Today's RangeC$10.84▼C$11.3550-Day RangeC$8.95▼C$11.7652-Week RangeC$5.23▼C$12.40Volume9,245 shsAverage Volume16,062 shsMarket CapitalizationC$403.35 millionAssets Under ManagementC$131.70 millionDividend Yield5.14%Net Expense Ratio0.60%Aggregate RatingModerate Buy ETF Overview Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Read More Profound Medical ExpensesTypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFsManagement Fee0.50%0.50%0.57%0.65%0.53%Other Expenses0.14%2.11%0.53%0.14%0.54%Total Expense0.64%1.40%0.75%0.72%0.73%Fee Waiver-0.04%-3.86%-0.67%-0.04%-0.68%Net Expense0.60%0.56%0.63%0.70%0.60% Receive PRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRN ETF News HeadlinesProfound Medical Boosts Orders, Narrows Loss as TULSA Adoption and Coverage Expand3 hours ago | tipranks.comProfound Medical (TSE:PRN) Upgraded at Raymond James FinancialJuly 30, 2026 | americanbankingnews.comALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.August 6 at 1:00 AM | Brownstone Research (Ad)Source Rock Royalties Declares Monthly Dividend and Issues Incentive RSUsJuly 16, 2026 | tipranks.comProfound Medical Highlights TULSA Advances at AUA 2026May 16, 2026 | theglobeandmail.comProfound to Showcase TULSA-PRO(R), the TULSA Procedure(TM) and the Future of iMRI at AUA2026May 15, 2026 | barrons.comSee More Headlines PRN ETF - Frequently Asked Questions How have PRN shares performed this year? Profound Medical's stock was trading at C$10.77 at the beginning of the year. Since then, PRN shares have increased by 3.1% and is now trading at C$11.10. How were Profound Medical's earnings last quarter? Profound Medical Corp. (TSE:PRN) posted its earnings results on Thursday, August, 6th. The company reported ($0.37) earnings per share (EPS) for the quarter. The business had revenue of $3.53 million for the quarter. Profound Medical had a negative trailing twelve-month return on equity of 78.75% and a negative net margin of 206.94%. How do I buy shares of Profound Medical? Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Profound Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include 10094 (IRD.TO) (IRD), Profound Medical (PROF), Whitecap Resources (WCP), Air Canada (AC), AXT (AXTI), Bank of Nova Scotia (BNS) and Enbridge (ENB). Fund Details IssuerInvesco Fund NameInvesco DWA Industrials Momentum ETF Tax ClassificationRegulated Investment Company Stock ExchangeTSECurrent SymbolTSE:PRN Inception Date10/12/2006 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.profoundmedical.com Phone647-476-1350Fund Focus Asset ClassEquity BenchmarkDWA Industrials Technical Leaders Index CategorySector FocusIndustrials Development LevelDeveloped Markets RegionNorth America Number of Holdings45 Fund Statistics Assets Under Management$131.70 million Average Daily Volume$18.99 thousand Discount/Premium-0.74% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares36,338,000Beta1.30 Creation Unit50,000 Creation Fee$500.00 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report Top 10 PRN HoldingsComfort Systems USA (NYSE:FIX)Holding Weight: 4.70%Howmet Aerospace (NYSE:HWM)Holding Weight: 4.55%Quanta Services (NYSE:PWR)Holding Weight: 4.07%Sterling Infrastructure (NASDAQ:STRL)Holding Weight: 3.96%Jabil (NYSE:JBL)Holding Weight: 3.47%EMCOR Group (NYSE:EME)Holding Weight: 3.35%Caterpillar (NYSE:CAT)Holding Weight: 3.20%TTM Technologies (NASDAQ:TTMI)Holding Weight: 2.86%Bel Fuse (NASDAQ:BELFB)Holding Weight: 2.81%MKS (NASDAQ:MKSI)Holding Weight: 2.80%Full Holdings DetailsPRN Sector ExposurePRN Industry Exposure This page (TSE:PRN) was last updated on 8/6/2026 by MarketBeat.com Staff. From Our PartnersA Wall Street Veteran's Weekly Trade for Any Market ConditionDave Aquino spent 25 years at Merrill Lynch and Vanguard studying one weekly options play that worked in bull,...Base Camp Trading | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
